Sangamo Therapeutics Inc. has received IND clearance from the FDA for ST-503, an investigational epigenetic regulator for the treatment of intractable pain due to idiopathic small fiber neuropathy ...
Vixotrigine, a non-opioid investigational pain drug, has the potential to address significant unmet medical needs of individuals living with chronic painful neuropathy CAMBRIDGE, Mass., Sept. 16, 2021 ...
Sangamo plans to initiate enrollment of patients in the Phase 1/2 study for ST-503 in mid-2025 RICHMOND, Calif.--(BUSINESS WIRE)-- Sangamo Therapeutics, Inc. (SGMO), a genomic medicine company, today ...
Small fiber sensory neuropathy is a neuromuscular disorder that affects millions of people. It can be caused by various conditions, such as diabetes or prediabetes. It can also occur on its own. Main ...
MINNEAPOLIS – The number of people experiencing numbness, tingling and pain in their feet with no known cause has been increasing over the last two decades, according at a new study published in the ...
The company states: “Sangamo (SGMO) Therapeutics announced that the FDA has cleared the investigational new drug application for its ST-503 program, an investigational epigenetic regulator for the ...
Janice asks the question: 'What Does Idiopathic Neuropathy Mean?' — -- Question: Hi. I'm Janice. I have peripheral neuropathy, but the doctor says it's idiopathic. What does that mean? Answer: ...
Prolonged, often disabling, small-fiber neuropathy in long COVID may be caused by a defective immune response, a small longitudinal study suggested. Peripheral neuropathy was identified in 59% of 17 ...
The number of people experiencing numbness, tingling and pain in their feet with no known cause has been increasing over the last two decades, according at a new study. Called small fiber neuropathy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback